论文部分内容阅读
目的:总结2μm激光汽化切除术同期治疗浅表性膀胱癌并前列腺增生(BPH)的临床经验。方法:回顾性分析采用2μm激光汽化切除术同期治疗浅表性膀胱癌并BPH患者24例的临床效果。结果:所有患者手术均获成功,手术时间为76~165min,平均118min,无膀胱穿孔等并发症发生。术后7~9天拔除尿管,发生暂时性尿失禁1例,继发性出血1例。术后随访3~24个月,5例膀胱肿瘤复发,无尿道狭窄等并发症发生。术后3个月,国际前列腺评分由术前(26.29±1.81)分降至术后(12.63±2.41)分(P<0.05),生活质量评分由术前(5.04±0.81)分降至术后(1.54±1.14)分(P<0.05),最大尿流率由术前(4.67±2.87)ml/s升至术后(14.83±2.14)ml/s(P<0.05),膀胱剩余尿量由术前(68.04±18.89)ml降至术后(21.88±11.38)ml(P<0.05)。结论:2μm激光汽化切除术是同期治疗浅表性膀胱癌并BPH的一种安全、有效的方法。
Objective: To summarize the clinical experience of 2 μm laser vaporization simultaneous treatment of superficial bladder cancer and benign prostatic hyperplasia (BPH). Methods: The clinical results of 24 patients with superficial bladder cancer and BPH treated with 2μm laser vaporization were retrospectively analyzed. Results: All the patients were operated successfully. The operation time was 76 ~ 165min with an average of 118min. No complications such as bladder perforation occurred. 7 to 9 days after removal of the catheter, a case of temporary urinary incontinence, 1 case of secondary bleeding. All cases were followed up for 3 to 24 months. Five cases of recurrent bladder tumor and no complications of urethral stricture occurred. At 3 months after operation, the international prostate score decreased from preoperative (26.29 ± 1.81) to postoperative (12.63 ± 2.41) (P <0.05), and the quality of life score decreased from preoperative (5.04 ± 0.81) to postoperative (1.54 ± 1.14) points (P <0.05). The maximum urinary flow rate increased from 4.67 ± 2.87 ml / s to 14.83 ± 2.14 ml / s (P <0.05) Preoperative (68.04 ± 18.89) ml decreased to (21.88 ± 11.38) ml postoperatively (P <0.05). Conclusion: 2 μm laser vaporization resection is a safe and effective method for the simultaneous treatment of superficial bladder cancer and BPH.